Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Astra reported for 9 months of 2023 by IFRS

11/20/23 ASTR

Sovcomflot reported for 9 months of 2023 by IFRS

11/20/23 FLOT

Institutional investor acquired 4.2% of Softline

11/20/23 SOFL

Bulgaria bans Russian oil supplies to Lukoil refinery

11/20/23 LKOH

CarMoney reported 9 months of 2023 by IFRS

11/20/23 CARM

UAC patents supersonic tactical aircraft

11/20/23 UNAC

QIWI reported for 9 months of 2023

11/17/23 QIWI

Chechia wants to continue importing NLMK products

11/17/23 NLMK

HeadHunter extended the acceptance of applications for exchange of receipts for shares

11/17/23 HEAD

Moscow Exchange launched a broker selection service

11/17/23 MOEX